company background image
RAMM

RAMM Pharma CNSX:RAMM Stock Report

Last Price

CA$0.01

Market Cap

CA$1.2m

7D

0%

1Y

-75.0%

Updated

23 Dec, 2024

Data

Company Financials

RAMM Stock Overview

Engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, and Poland. More details

RAMM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

RAMM Pharma Corp. Competitors

Price History & Performance

Summary of share price highs, lows and changes for RAMM Pharma
Historical stock prices
Current Share PriceCA$0.01
52 Week HighCA$0.065
52 Week LowCA$0.005
Beta0.28
1 Month Change-33.33%
3 Month Changen/a
1 Year Change-75.00%
3 Year Change-96.15%
5 Year Change-98.91%
Change since IPO-98.48%

Recent News & Updates

Recent updates

How Much Are RAMM Pharma Corp. (CSE:RAMM) Insiders Taking Off The Table?

Dec 18
How Much Are RAMM Pharma Corp. (CSE:RAMM) Insiders Taking Off The Table?

Shareholder Returns

RAMMCA PharmaceuticalsCA Market
7D0%2.4%-2.0%
1Y-75.0%-26.7%15.2%

Return vs Industry: RAMM underperformed the Canadian Pharmaceuticals industry which returned -26.7% over the past year.

Return vs Market: RAMM underperformed the Canadian Market which returned 15.2% over the past year.

Price Volatility

Is RAMM's price volatile compared to industry and market?
RAMM volatility
RAMM Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement12.0%
Market Average Movement8.2%
10% most volatile stocks in CA Market17.4%
10% least volatile stocks in CA Market2.9%

Stable Share Price: RAMM's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine RAMM's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1987n/aJack Burnettn/a

RAMM Pharma Corp. engages in the research and development, production, and sale of cannabinoid pharmacology and formulations, pharmaceuticals, cosmetics, and nutraceutical products in Uruguay, Italy, and Poland. The company also engages in the resale of medical supplies products; and sale of medical devices and consumables, and veterinarian products. It offers Cosmetic CBD+CBG.

RAMM Pharma Corp. Fundamentals Summary

How do RAMM Pharma's earnings and revenue compare to its market cap?
RAMM fundamental statistics
Market capCA$1.19m
Earnings (TTM)-CA$8.87m
Revenue (TTM)CA$4.47m

0.3x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RAMM income statement (TTM)
RevenueCA$4.47m
Cost of RevenueCA$3.96m
Gross ProfitCA$508.20k
Other ExpensesCA$9.38m
Earnings-CA$8.87m

Last Reported Earnings

Jul 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.074
Gross Margin11.37%
Net Profit Margin-198.51%
Debt/Equity Ratio0%

How did RAMM perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:48
End of Day Share Price 2024/12/19 00:00
Earnings2024/07/31
Annual Earnings2023/10/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RAMM Pharma Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution